FDA's acting CDER head Jacqueline Corrigan-Curay heads for the exit amid period of heavy turnover: reports

23rd June 2025 Uncategorised 0

Only a few days after reports emerged that the director of the FDA’s cell and gene therapy office had been abruptly put on administrative leave, a new departure shows an intense period of leadership turnover at the agency isn’t over.

More: FDA's acting CDER head Jacqueline Corrigan-Curay heads for the exit amid period of heavy turnover: reports
Source: fierce